Search - tctmd.com

Displaying 881 - 896 of 896

Sort: Relevancy | Date

Video

» Topical Discussion

Impact of Ultrathin Strut Stents and the Clinical Outcomes: An International Panel Discussion

October 10, 2019

Video

» Topical Discussion

SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients

October 8, 2019

Video

BIODEGRADE: A Large-Scale Randomized Trial of a Thin-Strut Bioabsorbable Polymer-Based DES vs. a Thick-Strut Bioabsorbable Polymer-Based DES in an All-Comers Population With Coronary Artery Disease

September 29, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Dean Kereiakis About the First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment

September 26, 2019

CME

TAVR in Expanded Patient Populations: Exploring the Next Frontier

CME

Low-Risk Patients: The Changing Face of TAVR

CME

TMVR: Preparing For The Next Revolution 2019

CME

Updates on TAVR in Low-Risk Patients

Partner Content

Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention

May 17, 2019

CME

The Treatment of Mitral Regurgitation in 2019 and Beyond

CME

TAVR in 2019: Appropriate Metrics for Success

CME

Optimizing the TAVR Patient Pathway

CME

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Partner Content

Ultrathin Orsiro DES: Novel technology, eye-catching cases and robust evidence

March 7, 2019

CME

New Clinical Data on TAVR use and Intermediate Risk Patients

CME

Advertisement

Impact of Ultrathin Strut Stents and the Clinical Outcomes: An International Panel Discussion

SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients

BIODEGRADE: A Large-Scale Randomized Trial of a Thin-Strut Bioabsorbable Polymer-Based DES vs. a Thick-Strut Bioabsorbable Polymer-Based DES in an All-Comers Population With Coronary Artery Disease

Dr. C. Michael Gibson Talks With Dr. Dean Kereiakis About the First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment

TAVR in Expanded Patient Populations: Exploring the Next Frontier

Low-Risk Patients: The Changing Face of TAVR

TMVR: Preparing For The Next Revolution 2019

Updates on TAVR in Low-Risk Patients

Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention

The Treatment of Mitral Regurgitation in 2019 and Beyond

TAVR in 2019: Appropriate Metrics for Success

Optimizing the TAVR Patient Pathway

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Ultrathin Orsiro DES: Novel technology, eye-catching cases and robust evidence

New Clinical Data on TAVR use and Intermediate Risk Patients

Recent TAVR Updates and Upcoming Studies at ACC 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content